RPAM
RGLS
Rhenman & Partners Asset Management’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,107
| Closed | -$97K | – | 92 |
|
|
2018
Q3 | $97K | Hold |
4,107
| – | – | 0.01% | 88 |
|
|
2018
Q2 | $325K | Hold |
4,107
| – | – | 0.03% | 84 |
|
|
2018
Q1 | $354K | Hold |
4,107
| – | – | 0.04% | 89 |
|
|
2017
Q4 | $513K | Sell |
4,107
-726
| -15% | -$90.7K | 0.07% | 83 |
|
|
2017
Q3 | $725K | Sell |
4,833
-114
| -2% | -$17.1K | 0.09% | 81 |
|
|
2017
Q2 | $585K | Hold |
4,947
| – | – | 0.08% | 88 |
|
|
2017
Q1 | $979K | Buy |
4,947
+1,046
| +27% | +$207K | 0.16% | 81 |
|
|
2016
Q4 | $1.05M | Buy |
3,901
+1,401
| +56% | +$378K | 0.2% | 83 |
|
|
2016
Q3 | $990K | Sell |
2,500
-417
| -14% | -$165K | 0.16% | 88 |
|
|
2016
Q2 | $1.01M | Buy |
2,917
+1,250
| +75% | +$434K | 0.18% | 87 |
|
|
2016
Q1 | $1.39M | Hold |
1,667
| – | – | 0.28% | 83 |
|
|
2015
Q4 | $1.74M | Hold |
1,667
| – | – | 0.26% | 87 |
|
|
2015
Q3 | $1.31M | Buy |
+1,667
| New | +$1.31M | 0.21% | 87 |
|